Literature DB >> 21209021

Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic glucose clamps in rhesus monkeys.

Ho-Won Lee1, Ranganath Muniyappa, Xu Yan, Lilly Q Yue, Ellen H Linden, Hui Chen, Barbara C Hansen, Michael J Quon.   

Abstract

The euglycemic glucose clamp is the reference method for assessing insulin sensitivity in humans and animals. However, clamps are ill-suited for large studies because of extensive requirements for cost, time, labor, and technical expertise. Simple surrogate indexes of insulin sensitivity/resistance including quantitative insulin-sensitivity check index (QUICKI) and homeostasis model assessment (HOMA) have been developed and validated in humans. However, validation studies of QUICKI and HOMA in both rats and mice suggest that differences in metabolic physiology between rodents and humans limit their value in rodents. Rhesus monkeys are a species more similar to humans than rodents. Therefore, in the present study, we evaluated data from 199 glucose clamp studies obtained from a large cohort of 86 monkeys with a broad range of insulin sensitivity. Data were used to evaluate simple surrogate indexes of insulin sensitivity/resistance (QUICKI, HOMA, Log HOMA, 1/HOMA, and 1/Fasting insulin) with respect to linear regression, predictive accuracy using a calibration model, and diagnostic performance using receiver operating characteristic. Most surrogates had modest linear correlations with SI(Clamp) (r ≈ 0.4-0.64) with comparable correlation coefficients. Predictive accuracy determined by calibration model analysis demonstrated better predictive accuracy of QUICKI than HOMA and Log HOMA. Receiver operating characteristic analysis showed equivalent sensitivity and specificity of most surrogate indexes to detect insulin resistance. Thus, unlike in rodents but similar to humans, surrogate indexes of insulin sensitivity/resistance including QUICKI and log HOMA may be reasonable to use in large studies of rhesus monkeys where it may be impractical to conduct glucose clamp studies.

Entities:  

Mesh:

Year:  2011        PMID: 21209021      PMCID: PMC3037167          DOI: 10.1210/en.2010-1164

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  41 in total

1.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

Authors:  R L Hanson; R E Pratley; C Bogardus; K M Narayan; J M Roumain; G Imperatore; A Fagot-Campagna; D J Pettitt; P H Bennett; W C Knowler
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

2.  QUICKI is a useful index of insulin sensitivity in subjects with hypertension.

Authors:  Hui Chen; Gail Sullivan; Lilly Q Yue; Arie Katz; Micheal J Quon
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04       Impact factor: 4.310

3.  Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.

Authors:  Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

4.  Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model.

Authors:  Hui Chen; Gail Sullivan; Michael J Quon
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

5.  Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal.

Authors:  Johannes B Ruige; Ilse L Mertens; Ellen Bartholomeeusen; Eveline Dirinck; Ele Ferrannini; Luc F Van Gaal
Journal:  Obesity (Silver Spring)       Date:  2006-07       Impact factor: 5.002

6.  Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells.

Authors:  Guolian Li; Eugene J Barrett; Hong Wang; Weidong Chai; Zhenqi Liu
Journal:  Endocrinology       Date:  2005-08-11       Impact factor: 4.736

Review 7.  Obesity in macaques: spontaneous and induced.

Authors:  J W Kemnitz
Journal:  Adv Vet Sci Comp Med       Date:  1984

8.  Central obesity in rhesus monkeys: association with hyperinsulinemia, insulin resistance and hypertriglyceridemia?

Authors:  N L Bodkin; J S Hannah; H K Ortmeyer; B C Hansen
Journal:  Int J Obes Relat Metab Disord       Date:  1993-01

Review 9.  Insulin resistance: the link between obesity and cardiovascular disease.

Authors:  Gerald M Reaven
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

Review 10.  Cardiovascular actions of insulin.

Authors:  Ranganath Muniyappa; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Endocr Rev       Date:  2007-05-24       Impact factor: 19.871

View more
  13 in total

1.  Acute Effects of Exercise Intensity on Insulin Sensitivity under Energy Balance.

Authors:  Gordon Fisher; Barbara A Gower; Fernando Ovalle; Christian E Behrens; Gary R Hunter
Journal:  Med Sci Sports Exerc       Date:  2019-05       Impact factor: 5.411

2.  Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.

Authors:  D H Abbott; B H Rayome; D A Dumesic; K C Lewis; A K Edwards; K Wallen; M E Wilson; S E Appt; J E Levine
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

Review 3.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

4.  Effects of preoperative and intraoperative glucose administration on glucose use and fat catabolism during laparotomy under sevoflurane anesthesia in fasted rats.

Authors:  Yoshiteru Mori; Takayuki Kitamura; Gaku Kawamura; Kanako Sato; Rui Sato; Yuko Araki; Yoshitsugu Yamada
Journal:  J Physiol Sci       Date:  2015-08-18       Impact factor: 2.781

5.  Estrogen deprivation in primate pregnancy leads to insulin resistance in offspring.

Authors:  Adina Maniu; Graham W Aberdeen; Terrie J Lynch; Jerry L Nadler; Soon O K Kim; Michael J Quon; Gerald J Pepe; Eugene D Albrecht
Journal:  J Endocrinol       Date:  2016-05-20       Impact factor: 4.286

6.  Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys.

Authors:  Marnie G Silverstein-Metzler; Carol A Shively; Thomas B Clarkson; Susan E Appt; J Jeffrey Carr; Stephen B Kritchevsky; Sara R Jones; Thomas C Register
Journal:  Psychoneuroendocrinology       Date:  2016-02-21       Impact factor: 4.905

7.  2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial.

Authors:  William E Kraus; Manjushri Bhapkar; Kim M Huffman; Carl F Pieper; Sai Krupa Das; Leanne M Redman; Dennis T Villareal; James Rochon; Susan B Roberts; Eric Ravussin; John O Holloszy; Luigi Fontana
Journal:  Lancet Diabetes Endocrinol       Date:  2019-07-11       Impact factor: 32.069

8.  Estrogen Promotes Microvascularization in the Fetus and Thus Vascular Function and Insulin Sensitivity in Offspring.

Authors:  Eugene D Albrecht; Graham W Aberdeen; Jeffery S Babischkin; Steven J Prior; Terrie J Lynch; Irene A Baranyk; Gerald J Pepe
Journal:  Endocrinology       Date:  2022-05-01       Impact factor: 5.051

9.  Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.

Authors:  Effie Tozzo; Gowri Bhat; Kyeongmi Cheon; Raul C Camacho
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

10.  Intrahepatic lipid, not visceral or muscle fat, is correlated with insulin resistance in older, female rhesus macaques.

Authors:  Michael P Chu; Bethany J Klopfenstein; Christine M Krisky; Henryk F Urbanski; William D Rooney; Steven G Kohama; Jonathan Q Purnell
Journal:  Obesity (Silver Spring)       Date:  2013-05-29       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.